Clinical Trials Directory

Trials / Completed

CompletedNCT04356703

Fetoscopic Open Spina Bifida Repair Using the SAFER Technique

Impact of Prenatal Correction of Spina Bifida Using Fetoscopy and the SAFER Technique on Long-term Neurodevelopment.

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Hospital Israelita Albert Einstein · Academic / Other
Sex
All
Age
12 Months – 6 Years
Healthy volunteers
Not accepted

Summary

Children submitted to fetoscopic in utero myelomeningocele repair using the SAFER (Skin-over-biocellulose for Anternatal FEtoscopic Repair) technique will evaluate at 30 months or more, regarding ambulation, neurodevelopment, urinary and fecal status.

Detailed description

Children submitted to fetoscopic in utero myelomeningocele repair using the SAFER (Skin-over-biocellulose for Anternatal FEtoscopic Repair) technique will evaluate the neuropsicomotor development at 30 months of chronological age. The mental evaluation will use the Bayley III and thePEDI neurodevelopmental scale. The motor development will use the difference between anatomic and motor level of the lesion. Urinary and fecal continence will be evaluated using clinical and ultrasonographic parameters. For the anatomical level determination, immaging of the spine at the lesion level will be used. Motor level and ambulation will be evaluated through standard clinical examination.

Conditions

Interventions

TypeNameDescription
OTHERNeuropsicomotor developmental testChildren will be evaluated trough Bayley III and PEDI scale. They also will be examined by pediatrician, neurosurgeon, orthopedics and phisiatry

Timeline

Start date
2017-04-01
Primary completion
2019-09-30
Completion
2020-03-01
First posted
2020-04-22
Last updated
2020-04-22

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT04356703. Inclusion in this directory is not an endorsement.